Total<unk>  The main goals of treatment are to decrease the risk of re-bleeding within the eye, corneal blood staining, and atrophy of the optic nerve. Small<unk> s can usually be treated on an outpatient basis. There is little evidence that most of the commonly used treatments for<unk>  (antifibrinolytic agents oral and systemic aminocaproic acid, tranexamic acid, and aminomethylbenzoic acid, corticosteroids systemic and topical, cycloplegics, miotics, aspirin, conjugated estrogens, traditional Chinese medicine, monocular versus bilateral patching, elevation of the head, and bed rest) are effective at improving visual acuity after two weeks. Surgery may be necessary for non-resolving<unk> s, or<unk> s that are associated with high pressure that does not respond to medication. Surgery can be effective for cleaning out the anterior chamber and preventing corneal blood staining. If pain management is necessary, acetaminophen can be used. Aspirin and ibuprofen should be avoided, because they interfere with platelets' ability to form a clot and consequently increase the risk of additional bleeding. Sedation is not usually necessary for patients with<unk> . Aminocaproic or tranexamic acids are often prescribed for<unk>  on the basis that they reduce the risk of rebleeding by inhibiting the conversion of plasminogen to plasmin, and thereby keeping clots stable. However, the evidence for their effectiveness is limited and aminocaproic acid may actually cause<unk> s to take longer to clear.
Hyphema
Alertness
Hypotension
Cornea
Apnea
Generalized hypoxia
Bradycardia
Hypothermia